Peshawar school massacre mastermind warns of more attacks

December 20, 2014

Islamabad, Dec 20: The terrorist who supervised the Peshawar school massacre has threatened more attacks, if the military and the intelligence agencies do not stop anti-terror operations, media reported Saturday.

In a video with English subtitles posted on Tehreek-i-Taliban Pakistan's (TTP) website, Umar Mansoor said that Tuesday's attack on the Army Public School which killed 148 people, including 132 children, was in retaliation to army operations, Dawn online reported.

Security agencies had intercepted communication between Umar Mansoor, also known as Khalifa Umar and Umar Narey, and the suicide squad during the seven-hour shooting spree at the school that helped identify him as the main handler.

Khalifa, TTP's 'commander' for Peshawar and the arms-manufacturing region of Darra Adamkhel, is head of the Tariq Geedar group.

Authorities traced a call to Afghanistan's Naziyan district in Afghanistan's Nangarhar province.

TTP spokesman, Mohammad Khurasani said in a statement Friday that TTP men had been "instructed not to target kids in the primary section of the school".

"The fidayeen (suicide attackers) were kept informed of these instructions during the attack," he said.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments